The stock is up 77c to $28.77 in premarket trading.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALKS:
- Alkermes Gains FDA Breakthrough Status for Narcolepsy Drug
- Alkermes granted Breakthrough Therapy designation for alixorexton by FDA
- Centessa price target raised to $42 from $33 at B. Riley
- Jefferies expects Avadel-Alkermes deal to close
- Avadel Pharmaceuticals price target raised to $22.50 from $20 at Wells Fargo